Cargando…
A Feasibility Study on the Identification of Potential Biomarkers in Pulmonary Embolism Using Proteomic Analysis
Acute pulmonary embolism (PE) is a common emergency with a high morbidity and mortality. Most clinical presentations are non-specific and there is a lack of suitable biomarkers for PE. For example, the traditional D-dimer tests shows a rather high sensitivity for PE, but yet a rather low positive pr...
Autores principales: | Granholm, Fredrik, Bylund, Dan, Shevchenko, Ganna, Lind, Sara B., Henriksson, Anders E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796107/ https://www.ncbi.nlm.nih.gov/pubmed/35043712 http://dx.doi.org/10.1177/10760296221074347 |
Ejemplares similares
-
Aptamer-based multiplexed proteomic technology for biomarker discovery
por: Gold, Larry, et al.
Publicado: (2010) -
Identification of Potential Plasma Biomarkers for Abdominal Aortic Aneurysm Using Tandem Mass Tag Quantitative Proteomics
por: Henriksson, Anders E., et al.
Publicado: (2018) -
Dysregulation of Biomarkers of Hemostatic Activation and Inflammatory Processes are Associated with Adverse Outcomes in Pulmonary Embolism
por: Darwish, Iman, et al.
Publicado: (2022) -
Predictive Role of Blood Cellular Indices and Their Relationship with
Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in
Pulmonary Embolism
por: Kantarcioglu, Bulent, et al.
Publicado: (2022) -
The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients
por: Kantarcioglu, Bulent, et al.
Publicado: (2022)